[Individual glycoside therapy using serum concentration determination in heart insufficiency of horses].
23 horses and one donkey with congestive heart failure are treated with a standardized methyldigoxin dose (0.0032 mg/kg of body weight). The therapy is controlled by the serum concentration of the cardiac glycoside. 4 horses have a higher and 13 horses a lower serum concentration as necessary for therapeutic approach. The influence of additional diseases and medications is demonstrated. Finally a rule for the evaluation of the individual therapeutic glycoside-dose is given.
Staudacher
G
G
D000818:Animals; D004077:Digoxin / Q000031:analogs & derivatives*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000662:veterinary*; D006734:Horse Diseases / Q000188:drug therapy*; D006736:Horses; D008297:Male; D008520:Medigoxin / Q000097:blood / Q000627:therapeutic use*; D010527:Perissodactyla
D004077:Digoxin; D008520:Medigoxin
Individuelle Glykosidtherapie mittels Serumkonzentrationbestimmung bei der Herzinsuffizienz des Pferdes.